Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain
Juan Antonio Castillo-Polo, Marta Hernández-García, María Isabel Morosini, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 5, pp. 1259-1264
Closed Access | Times Cited: 17

Showing 17 citing articles:

Klebsiella pneumoniae carbapenemase variants: the new threat to global public health
Li Ding, Siquan Shen, Jing Chen, et al.
Clinical Microbiology Reviews (2023) Vol. 36, Iss. 4
Open Access | Times Cited: 65
International and regional spread of carbapenem-resistant Klebsiella pneumoniae in Europe
Mabel Budia-Silva, Tomislav Kostyanev, Stefany Ayala-Montaño, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate
André Birgy, Christina Nnabuife, Timothy Palzkill
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 3
Open Access | Times Cited: 4
Deciphering mechanisms affecting cefepime-taniborbactam in vitro activity in carbapenemase-producing Enterobacterales and carbapenem-resistant Pseudomonas spp. isolates recovered during a surveillance study in Spain
Marta Hernández-García, María García-Castillo, Marta Nieto-Torres, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2023) Vol. 43, Iss. 2, pp. 279-296
Closed Access | Times Cited: 10
In vitro activity of cefiderocol and other newly approved antimicrobials against multi-drug resistant Gram-negative pathogens recovered in intensive care units in Spain and Portugal
Desirèe Gijón, María García-Castillo, María del Carmen Fernández-López, et al.
Revista Española de Quimioterapia (2023) Vol. 37, Iss. 1, pp. 69-77
Open Access | Times Cited: 7
Outbreak of NDM-5-producing Klebsiella pneumoniae ST307: an emerging high-risk antimicrobial resistance clone in Shanghai, China
Junying Zhu, Guangyu Wang, Min Li
mSystems (2024) Vol. 9, Iss. 4
Open Access | Times Cited: 2
The Effectiveness of Imipenem–Relebactam against Ceftazidime-Avibactam Resistant Variants of the KPC-2 β-Lactamase
Krisztina M. Papp‐Wallace, Melissa D. Barnes, Magdalena A. Taracila, et al.
Antibiotics (2023) Vol. 12, Iss. 5, pp. 892-892
Open Access | Times Cited: 4
Murepavadin induces envelope stress response and enhances the killing efficacies of β-lactam antibiotics by impairing the outer membrane integrity of Pseudomonas aeruginosa
Xiaoya Wei, Jiacong Gao, Congjuan Xu, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 4
Comparative Genomic Analysis Reveals the Emergence of ST-231 and ST-395 Klebsiella pneumoniae Strains Associated with the High Transmissibility of blaKPC Plasmids
Muna AL-Muzahmi, Meher Rizvi, Munawr AL-Quraini, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2411-2411
Open Access | Times Cited: 2
Evolution of ceftazidime-avibactam and cefiderocol resistance in ST131-H30R1- Escherichia coli isolates with KPC-3 mutants and application of FTIR biotyping
Juan Antonio Castillo-Polo, Marta Hernández-García, Ainhize Maruri-Aransolo, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 4
Open Access
Overexpression of β-lactamase genes ( bla KPC, bla SHV ) and novel CirA deficiencies contribute to decreased cefiderocol susceptibility in carbapenem-resistant Klebsiella pneumoniae before its approval in China
Hanxu Hong, Lin-Ping Fan, Wenbo Shi, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 11
Closed Access
Mutant prevention concentrations, in vitro resistance evolution dynamics, and mechanisms of resistance to imipenem and imipenem/relebactam in carbapenem-susceptible Klebsiella pneumoniae isolates showing ceftazidime/avibactam resistance
Tania Blanco-Martín, Lucía González-Pinto, Pablo Aja‐Macaya, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access
Comparative Genomic Analysis Reveals Emergence of ST-231 and ST-395 Klebsiella pneumoniae Strains Associated with High Transmissibility of blaKPC Plasmids
Muna AL-Muzahmi, Meher Rizvi, Manawr AL-Quraini, et al.
(2023)
Open Access | Times Cited: 1
Comparative De Novo and Pan-Genome Analysis of MDR Nosocomial Bacteria Isolated from Hospitals in Jeddah, Saudi Arabia
Molook Alghamdi, Effat Al-Judaibi, Mohammed Al-Rashede, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2432-2432
Open Access | Times Cited: 1
Ultrafast detection of β-lactamase resistance in Klebsiella pneumoniae from blood culture by nanopore sequencing
Matxalen Vidal‐García, Mikel Joseba Urrutikoetxea Gutiérrez, Juan C Forero Niampira, et al.
Future Microbiology (2023) Vol. 18, Iss. 18, pp. 1309-1317
Closed Access | Times Cited: 1
Predictive role of culture-based MIC testing vs. genotyping for carbapenem-resistant Enterobacterales in a non-universal screening, highly resourced setting
Amani Alnimr
Electronic Journal of General Medicine (2023) Vol. 20, Iss. 4, pp. em495-em495
Open Access
International and regional spread of carbapenem-resistantKlebsiella pneumoniaein Europe
Mabel Budia Silva, Tomislav Kostyanev, Stefany Ayala Montaño, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top